Embracing regulatory ambition to shape Canada’s future in health-care innovation

At this pivotal moment, Canada has the ability not only to redefine its healthcare landscape, but also to lead globally in the sector

Canada must establish a globally competitive public policy and regulatory environment which supports and drives innovation forward, writes Andrew Casey, president and CEO of BIOTECanada.Image courtesy of Fayette Reynolds M.S./Pexels

Opinion

BY ANDREW CASEY

April 29, 2024

As a result of game-changing innovations emerging from the biotechnology sector globally, health care is undergoing a truly transformational phase. With its long history of science, research, and health-related biotech innovation, Canada is well-positioned to be a leadi...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy